/ BSX


Boston Scientific Corporation’s Q4 2024 Net Sales Surge by 22.4%, Exceeding Expectations
/ Earnings

Boston Scientific Corporation’s Q4 2024 Net Sales Surge by 22.4%, Exceeding Expectations

Boston Scientific Corporation reported robust financial results in Q4 2024, with net sales reaching $4.561 billion, a 22.4% increase from the previous year.

February 05, 2025
BSX Reports $4.12 Billion in Q2 2024 Net Sales, Up 14.5% from Q2 2023

BSX Reports $4.12 Billion in Q2 2024 Net Sales, Up 14.5% from Q2 2023

Boston Scientific Corporation (NYSE: BSX) has reported robust financial results for the second quarter of 2024.

July 24, 2024
Boston Scientific (BSX) Beats Expectations with $3.8 Billion in Q1 Net Sales

Boston Scientific (BSX) Beats Expectations with $3.8 Billion in Q1 Net Sales

Boston Scientific Corporation (NYSE: BSX) reported a significant growth in net sales for the first quarter of 2024, reaching $3.856 billion.

April 24, 2024
Boston Scientific Corporation (BSX) Reports $0.50 Adjusted EPS, $3.73B Revenue for Q3

Boston Scientific Corporation (BSX) Reports $0.50 Adjusted EPS, $3.73B Revenue for Q3

Boston Scientific reports Q3 results with a strong revenue of $3.73 billion and an adjusted EPS of $0.50.

January 31, 2024

Get Trade Ideas and Market Insights Delivered to You Premarket - Every Day

X